2022 Q1 Form 10-Q Financial Statement

#000155837022007666 Filed on May 09, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1 2020 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $26.02M $14.39M $10.81M
YoY Change 80.76% 308.92% 144.02%
% of Gross Profit
Research & Development $61.86M $91.81M $27.75M
YoY Change -32.62% 984.22% 394.65%
% of Gross Profit
Depreciation & Amortization $0.00 $0.00
YoY Change
% of Gross Profit
Operating Expenses $87.88M $106.2M $38.55M
YoY Change -17.25% 785.79% 283.96%
Operating Profit -$87.88M -$106.2M
YoY Change -17.25% 785.79%
Interest Expense -$258.0K $127.0K $200.0K
YoY Change -303.15% -12800.0%
% of Operating Profit
Other Income/Expense, Net -$1.492M -$19.13M $2.460M
YoY Change -92.2% -15284.13% 24500.0%
Pretax Income -$89.63M -$125.2M -$38.24M
YoY Change -28.41% 955.3% 281.64%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$89.60M -$125.2M -$38.24M
YoY Change -28.44% 955.3% 281.64%
Net Earnings / Revenue
Basic Earnings Per Share -$0.46 -$0.72
Diluted Earnings Per Share -$0.43 -$0.72 -$230.4K
COMMON SHARES
Basic Shares Outstanding 196.5M 174.3M 164.9M shares
Diluted Shares Outstanding 196.5M 174.3M

Balance Sheet

Concept 2022 Q1 2021 Q1 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $203.6M $587.0M $629.8M
YoY Change -65.32%
Cash & Equivalents $203.6M $587.0M $629.8M
Short-Term Investments
Other Short-Term Assets $34.37M $25.99M $24.70M
YoY Change 32.26%
Inventory
Prepaid Expenses
Receivables $5.000K $21.00K
Other Receivables $0.00 $0.00
Total Short-Term Assets $237.9M $613.0M $654.4M
YoY Change -61.19% 30212.41%
LONG-TERM ASSETS
Property, Plant & Equipment $407.8M $154.9M $101.7M
YoY Change 163.22% 401.4%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $14.00M
YoY Change
Total Long-Term Assets $422.8M $166.0M $112.8M
YoY Change 154.64% 259.3%
TOTAL ASSETS
Total Short-Term Assets $237.9M $613.0M $654.4M
Total Long-Term Assets $422.8M $166.0M $112.8M
Total Assets $660.8M $779.1M $767.2M
YoY Change -15.19% 2187.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $13.78M $58.96M $32.54M
YoY Change -76.63% 1705.55%
Accrued Expenses $39.28M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $203.1M $67.00M $34.07M
YoY Change 203.06% 36.35%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $1.015M $1.000M
YoY Change -100.0%
Other Long-Term Liabilities $3.189M $7.750M $101.4M
YoY Change -58.85%
Total Long-Term Liabilities $3.189M $8.765M $1.000M
YoY Change -63.62%
TOTAL LIABILITIES
Total Short-Term Liabilities $203.1M $67.00M $34.07M
Total Long-Term Liabilities $3.189M $8.765M $1.000M
Total Liabilities $206.2M $75.77M $136.5M
YoY Change 172.21% 446.14%
SHAREHOLDERS EQUITY
Retained Earnings -$634.4M -$259.7M -$134.4M
YoY Change 144.33% 1193.82%
Common Stock $20.00K $18.00K $17.00K
YoY Change 11.11% 142.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $454.5M $703.3M $630.7M
YoY Change
Total Liabilities & Shareholders Equity $660.8M $779.1M $767.2M
YoY Change -15.19% 2187.07%

Cashflow Statement

Concept 2022 Q1 2021 Q1 2020 Q4
OPERATING ACTIVITIES
Net Income -$89.60M -$125.2M -$38.24M
YoY Change -28.44% 955.3% 281.64%
Depreciation, Depletion And Amortization $0.00 $0.00
YoY Change
Cash From Operating Activities -$69.03M -$71.52M -$28.72M
YoY Change -3.48% 810.5%
INVESTING ACTIVITIES
Capital Expenditures $21.90M $54.26M -$58.24M
YoY Change -59.65%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$21.90M -$54.26M -$58.24M
YoY Change -59.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $477.0K $1.050M $500.0M
YoY Change -54.57% -82.86%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 50.48M 83.07M 697.0M
YoY Change -39.23% 1256.18%
NET CHANGE
Cash From Operating Activities -69.03M -71.52M -28.72M
Cash From Investing Activities -21.90M -54.26M -58.24M
Cash From Financing Activities 50.48M 83.07M 697.0M
Net Change In Cash -40.45M -42.72M 610.1M
YoY Change -5.3% 2369.25%
FREE CASH FLOW
Cash From Operating Activities -$69.03M -$71.52M -$28.72M
Capital Expenditures $21.90M $54.26M -$58.24M
Free Cash Flow -$90.93M -$125.8M $29.52M
YoY Change -27.71% 1501.32%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.43
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.72
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
196503000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
174325000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
196503000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
174325000
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001759546
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
196400000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
196400000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
196391349
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
196391349
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-38821
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
Lordstown Motors Corp.
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
83-2533239
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
2300 Hallock Young Road
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Lordstown
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
OH
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
44481
CY2022Q1 dei City Area Code
CityAreaCode
234
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
285-4001
CY2022Q1 dei Security12b Title
Security12bTitle
Class A Common Stock
CY2022Q1 dei Trading Symbol
TradingSymbol
RIDE
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
197399056
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
203564000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
244016000
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
34373000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
47121000
CY2022Q1 us-gaap Assets Current
AssetsCurrent
237937000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
291137000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
407817000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
382746000
CY2022Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
1000000
CY2021Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
1000000
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13997000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13900000
CY2022Q1 us-gaap Assets
Assets
660751000
CY2021Q4 us-gaap Assets
Assets
688783000
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
13781000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
12098000
CY2022Q1 ride Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
39278000
CY2021Q4 ride Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
35507000
CY2022Q1 ride Lease Deposit Liability Current
LeaseDepositLiabilityCurrent
150000000
CY2021Q4 ride Lease Deposit Liability Current
LeaseDepositLiabilityCurrent
100000000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
203059000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
147605000
CY2022Q1 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
3189000
CY2021Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
1578000
CY2022Q1 us-gaap Liabilities
Liabilities
206248000
CY2021Q4 us-gaap Liabilities
Liabilities
149183000
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
196980828
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
196391349
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
20000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
19000
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1088925000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1084390000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-634442000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-544809000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
454503000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
539600000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
660751000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
688783000
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
26019000
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
14394000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
61864000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
91812000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
87883000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
106206000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-87883000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-106206000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1492000
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-19132000
CY2022Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-258000
CY2021Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
127000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-89633000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-125211000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-89633000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-125211000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.72
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
196503000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
174325000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
539600000
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
616000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3920000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-89633000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
454503000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
630738000
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1050000
CY2021Q1 ride Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
194798000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1940000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-125211000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
703315000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-89633000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-125211000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3920000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1940000
CY2022Q1 ride Other Non Cash Changes
OtherNonCashChanges
4420000
CY2021Q1 ride Other Non Cash Changes
OtherNonCashChanges
19138000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-16000
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-9987000
CY2021Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1325000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1490000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
27418000
CY2022Q1 ride Increase Decrease In Accrued Liabilities And Due To Related Party
IncreaseDecreaseInAccruedLiabilitiesAndDueToRelatedParty
3763000
CY2021Q1 ride Increase Decrease In Accrued Liabilities And Due To Related Party
IncreaseDecreaseInAccruedLiabilitiesAndDueToRelatedParty
6504000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-69033000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-71520000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
21896000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
54264000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21896000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-54264000
CY2022Q1 ride Proceeds From Down Payment
ProceedsFromDownPayment
50000000
CY2021Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
82016000
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
477000
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1050000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
50477000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
83066000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-40452000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-42718000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
244016000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
629761000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
203564000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
587043000
CY2022Q1 ride Noncash Or Part Noncash Acquisition Fixed Assets Acquired Via Debt
NoncashOrPartNoncashAcquisitionFixedAssetsAcquiredViaDebt
5336000
CY2021Q1 ride Noncash Or Part Noncash Acquisition Fixed Assets Acquired Via Debt
NoncashOrPartNoncashAcquisitionFixedAssetsAcquiredViaDebt
4599000
CY2021Q4 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
230000000
CY2022Q1 ride Sale Of Assets First Payment Receivable
SaleOfAssetsFirstPaymentReceivable
200000000
CY2022Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
50000000
CY2022Q1 ride Sale Leaseback Transaction Area Of Land
SaleLeasebackTransactionAreaOfLand
30000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
55.8817
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 ride Conversion Of Stock Shares Issued Per Share Tendered
ConversionOfStockSharesIssuedPerShareTendered
1
CY2020Q4 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
7000000
CY2020Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
50000000
CY2020Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10.00
CY2020Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
500000000
CY2020Q4 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
4000000
CY2020Q4 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
40000000
CY2020Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
10.00
CY2020Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1600000
CY2020Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
10.00
CY2020Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
CY2020Q4 ride Stock Issued During Period Shares Exercise Of Warrants
StockIssuedDuringPeriodSharesExerciseOfWarrants
2700000
CY2020Q4 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
30700000
CY2021Q1 ride Stock Issued During Period Shares Exercise Of Warrants
StockIssuedDuringPeriodSharesExerciseOfWarrants
600000
CY2021Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
82000000.0
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
203600000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-634400000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-89600000
CY2022Q1 us-gaap Substantial Doubt About Going Concern Within One Year
SubstantialDoubtAboutGoingConcernWithinOneYear
true
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates in Financial Statement Preparation</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">The preparation of financial statements in accordance with GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, if any, at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p>
CY2022Q1 us-gaap Derivatives Embedded Derivatives
DerivativesEmbeddedDerivatives
<p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;padding-bottom:12pt;margin:0pt;">Warrants</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;">The Company accounts for its Public and Private Warrants as described in Note 3 in accordance with the guidance contained in ASC Topic 815-40-15-7D and 7F under which the Public Warrants and Private Warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Public and Private Warrants as liabilities at their fair value and adjusts the Public and Private </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;">Warrants to fair value at each reporting period or at the time of settlement. Any change in fair value is recognized in the statement of operations.  The Company accounts for BGL Warrants as equity as these warrants qualify as share-based compensation under ASC Topic 718.</p>
CY2021Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
100900000
CY2021Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
82000000.0
CY2021Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3900000
CY2022Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3900000
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3900000
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1520000
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
19138000
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
407817000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
382746000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
407817000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
382746000
CY2022Q1 us-gaap Depreciation
Depreciation
0
CY2021 us-gaap Depreciation
Depreciation
0
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11100000
CY2022Q1 ride Shares Authorized Common And Preferred
SharesAuthorizedCommonAndPreferred
312000000
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
12000000
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
197000000.0
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
196400000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
196503000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
174325000

Files In Submission

Name View Source Status
0001558370-22-007666-index-headers.html Edgar Link pending
0001558370-22-007666-index.html Edgar Link pending
0001558370-22-007666.txt Edgar Link pending
0001558370-22-007666-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
ride-20220331.xsd Edgar Link pending
ride-20220331x10q.htm Edgar Link pending
ride-20220331x10q_htm.xml Edgar Link completed
ride-20220331xex31d1.htm Edgar Link pending
ride-20220331xex31d2.htm Edgar Link pending
ride-20220331xex32d1.htm Edgar Link pending
ride-20220331xex32d2.htm Edgar Link pending
ride-20220331_cal.xml Edgar Link unprocessable
ride-20220331_def.xml Edgar Link unprocessable
ride-20220331_lab.xml Edgar Link unprocessable
ride-20220331_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending